Publication: Effects of 18-month Vildagliptin Treatment on Portal Vein Pressure and Hepatosteatosis
Files
Program
Authors
KARATOPRAK, CUMALİ
KISKAÇ, MUHARREM
Kilicarslan, Rukiye
ÇAKIRCA, MUSTAFA
Aydin, Sinem
Ozkan, Tuba
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Objective: Patients with type 2 diabetes have an increased tendency to develop hepatosteatosis. The effects of drugs used to treat diabetes on the liver, regardless of the disease, are unknown.The aim of this study was to investigate the effects of vildagliptin, a dipeptidyl peptidase-4 inhibitor, on the portal vein pressure and hepatosteatosis in patients with type 2 diabetes in the 18 months of follow-up.
Description
Source:
Keywords:
Keywords
Citation
KARATOPRAK C., Kilicarslan R., ÇAKIRCA M., Aydin S., Ozkan T., ZORLU M., KISKAÇ M., -Effects of 18-month Vildagliptin Treatment on Portal Vein Pressure and Hepatosteatosis-, BEZMIALEM SCIENCE, cilt.7, ss.317-321, 2019